-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Using Multi-omics Discovery to Understand the Mechanisms of Hemolytic Anemia in Sickle Cell Disease and Transfusion Medicine

Program: Scientific Workshops @ ASH
Session: Exploring the ‘Omics of Cardiovascular and Renal Sequelae of Sickle Cell Disease
Friday, December 4, 2020, 8:15 AM-9:05 AM

Mark T. Gladwin, MD

University of Pittsburgh, Pittsburgh, PA

Disclosures: Gladwin: Globin Solutions: Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees, Patents & Royalties: Not relevant to SCD; Bayer: Consultancy, Research Funding; Actelion: Consultancy; Pfizer: Consultancy; Novartis: Consultancy.

Previous Presentation | Next Presentation >>